Page 98 - ASHG 2013 Program Guide

INVITED AND PLATFORM SESSIONS  
 85
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Wednesday, October 23
2:00
PM
–4:15
PM
Concurrent Platform (abstract-driven)
Session A (10-18)
SESSION 15 – Psychiatric Disease: GWAS to Genes
Room 253, Level 2, Convention Center
Moderators
:
Brian O’Roak, Univ. of Washington;
Joseph D. Buxbaum, Mount Sinai Sch. of Med.
52
/2:00
Using brain molecular QTLs to identify
novel risk genes shared by multiple psychiatric
diseases.
C. Liu, C. Zhang, C. Chen, J. A. Badner, N.
Alliey-Rodriguez, E. S. Gershon, E. R. Gamazon, N. J.
Cox, TSAICG, IOCDF-GC.
53
/2:15
Functional enrichment analysis on
genome-wide epistasis patterns reveals pathway
interactions in bipolar disorder.
S. Prabhu, N.
Clinger, B. Burnett, I. Pe’er.
54
/2:30
Role of the Wnt signaling pathway in
bipolar disorder susceptibility: Gene-set analysis
of SNP-BMI interaction effects.
M. A. Simonson, S.
J. Winham, G. D. Jenkins, A. Cuellar Barboza, M. H.
Jang, S. McElroy, M. A. F. Frye, J. M. Biernacka.
55
/2:45
A novel variant in the HERG3 voltage-gated
potassium ion channel gene (
KCHN7
)
is associated
with bipolar spectrum disorder among the Old
Order Amish.
A. R. Benkert, E. G. Puffenberger, S.
Markx, S. M. Paul, R. N. Jinks, B. Georgi, T. Hoshi, A.
McDonald, M. B. First, W. Liu, A. Heaps, Y. Tian, A.
Chakravarti, D. H. Morton, M. Bucan, K. A. Strauss.
56
/3:00
Exome sequencing in sporadic cases of
schizophrenia and functional studies identify 21
putative candidate genes for schizophrenia and
establish the
RGS12
gene as a strong candidate.
M. Guipponi, F. Santoni, V. Setola, E. Oestreich,
C. Gehrig, M. Rotharmel, M. Cuenca, O. Guilin, D.
Dikeos, G. Papadimitriou, A. Méary, F. Schürhoff,
S. Jamain, M. Leboyer, D. Rujescu, A. Pulver, S.
Moy, D. Campion, A. Malafosse, D. Siderovski, S. E.
Antonarakis.
57
/3:15
Rare duplications in
RB1CC1
are
associated with schizophrenia in large datasets
from Europe.
F. Degenhardt, M. A. Pfohl, L. Lennertz,
L. Priebe, J. Strohmaier, S. H. Witt, A. Hofmann, T.
Becker, R. Mössner, W. Maier, I. Nenadic, S. Meier, J.
Buizer-Voskamp, R. A. Ophoff, D. Rujescu, I. Giegling,
A. Ingason, M. Wagner, A. Meyer-Lindenberg, H.
Walter, S. Moebus, A. Corvin, H. Stefánsson, T. G.
Schulze, M. Rietschel, S. Cichon, M. M. Nöthen,
GROUP Consortium, Wellcome Trust Case Control
Consortium 2, International Schizophrenia Consortium.
58
/3:30
Variants in
NRG3
associated with delusion
have regulatory potential and differentially bind to
nuclear proteins.
M. Zeledon, M. Taub, N. Eckart, M.
Beer, R. Wang, M. Szymanski, P. Chen, A. E. Pulver, J.
A. McGrath, P. Wolyniec, D. Avramopoulos, A. Sawa,
D. Valle.
59
/3:45
Testing genetic associations with addiction
phenotypes using moderate-depth whole genome
sequencing.
S. I. Vrieze, S. Feng, X. Zhan, M. B.
Miller, G. Jun, M. K. Trost, A. Tan, J. Bragg-Gresham,
M. Flickinger, L. Scott, A. Locke, H. M. Kang, S. Levy,
R. M. Myers, M. Boehnke, W. G. Iacono, M. McGue,
G. R. Abecasis.
60
/4:00
A genome-wide association study of
alcohol dependence in the Irish affected sib pair
study of alcohol dependence.
A. E. Adkins, L. M.
Hack, T. B. Bigdeli, B. T. Webb, J. C. Bettinger, A. G.
Davies, M. S. Grotewiel, C. A. Prescott, D. M. Dick, K.
S. Kendler, B. P. Riley.
INVITED AND PLATFORM SESSIONS